0       0

HFSA's 20th Annual Scientific Meeting


Navigating the Slippery Slope of Advanced HFS: A Look Beyond the Usual Suspects


Description

  • KEYNOTE: Cell Therapy to Prevent and Treat HF
  • Chronic Inotrope Therapy in End Stage HF: Better than an LVAD
  • Inotropes are no REMATCH for an LVAD!
  • One Size Does Not Fit All: What (and When) is the Best Treatment Option in the Acutely Decompensated HF Patient?
  • Acute HF: Phenotype and choice of vasoactive agent - Vasodilators or Inotropes
  • Beyond Drugs: ECMO, Impella, or Nothing? Timing and Exit Strategy
  • Chronic Aortic Counterpulsation: Kinder, Gentler Assist?
  • Panel Discussion

Moderator(s):

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content